These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1158 related articles for article (PubMed ID: 2465525)
1. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP; Sefton BM Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525 [TBL] [Abstract][Full Text] [Related]
2. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Kamps MP; Sefton BM Oncogene; 1988 Apr; 2(4):305-15. PubMed ID: 2452398 [TBL] [Abstract][Full Text] [Related]
3. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src. Lau AF Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Ellis C; Moran M; McCormick F; Pawson T Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011 [TBL] [Abstract][Full Text] [Related]
5. Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa. Wendler PA; Boschelli F Oncogene; 1989 Feb; 4(2):231-6. PubMed ID: 2494631 [TBL] [Abstract][Full Text] [Related]
6. Localization of major potential substrates of p60v-src kinase in the plasma membrane matrix fraction. Hamaguchi M; Hanafusa H Oncogene Res; 1989; 4(1):29-37. PubMed ID: 2497423 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus. Patschinsky T; Hunter T; Sefton BM J Virol; 1986 Jul; 59(1):73-81. PubMed ID: 2423705 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1. Uehara Y; Murakami Y; Sugimoto Y; Mizuno S Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Cobb BS; Parsons JT Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368 [TBL] [Abstract][Full Text] [Related]
10. From c-src to v-src, or the case of the missing C terminus. Sefton BM; Hunter T Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701 [TBL] [Abstract][Full Text] [Related]
11. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro. Tanaka A; Salem M; Eckroade RJ; Fujita DJ Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536 [TBL] [Abstract][Full Text] [Related]
12. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src. Akiho H; Tokumitsu Y; Noda M; Nomura Y Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735 [TBL] [Abstract][Full Text] [Related]
13. Characterization of avian and viral p60src proteins expressed in yeast. Kornbluth S; Jove R; Hanafusa H Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4455-9. PubMed ID: 2440023 [TBL] [Abstract][Full Text] [Related]
14. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells. Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036 [TBL] [Abstract][Full Text] [Related]
15. Modification of carboxyl-terminal region is the cause of activation of the src gene in avian sarcoma virus S2. Ikawa S; Yamamoto T; Toyoshima K Jpn J Cancer Res; 1986 Jul; 77(7):611-4. PubMed ID: 3017908 [TBL] [Abstract][Full Text] [Related]
16. Properties of tripartite chimeras between Src and Lck. Kashishian A; MacAuley A; Cooper JA Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908 [TBL] [Abstract][Full Text] [Related]
17. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants. Jove R; Hanafusa T; Hamaguchi M; Hanafusa H Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707 [TBL] [Abstract][Full Text] [Related]
18. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Bustelo XR; Ledbetter JA; Barbacid M Nature; 1992 Mar; 356(6364):68-71. PubMed ID: 1311423 [TBL] [Abstract][Full Text] [Related]
19. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725 [TBL] [Abstract][Full Text] [Related]
20. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation. Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]